Mojtaba Memariani

Dr. Mojtaba Memariani


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2019 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
HMHamed Memariani
Hamed Memariani
MMMojtaba Memariani
Mojtaba Memariani
HMHamideh Moravvej
Hamideh Moravvej
MSMohammad Shahidi-Dadras
Mohammad Shahidi-Dadras

1 March 2019 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HMHamed Memariani
Hamed Memariani
MMMojtaba Memariani
Mojtaba Memariani
MSMohammad Shahidi-Dadras
Mohammad Shahidi-Dadras
SNSoheila Nasiri
Soheila Nasiri
MAMaziar Mohammad Akhavan
Maziar Mohammad Akhavan
HMHamideh Moravvej
Hamideh Moravvej

6 September 2019 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HMHamed Memariani
Hamed Memariani
MMMojtaba Memariani
Mojtaba Memariani
AGAbdolmajid Ghasemian
Abdolmajid Ghasemian

14 February 2023 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HMHamed Memariani
Hamed Memariani
MMMojtaba Memariani
Mojtaba Memariani

4 June 2020 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HMHamed Memariani
Hamed Memariani
MMMojtaba Memariani
Mojtaba Memariani

18 April 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MMMojtaba Memariani
Mojtaba Memariani
SPShahin Najar Peerayeh
Shahin Najar Peerayeh
TSTaghi Zahraei Salehi
Taghi Zahraei Salehi
SMSeyyed Khalil Shokouhi Mostafavi
Seyyed Khalil Shokouhi Mostafavi
Background: Antibiotic resistance is widespread among diarrheagenic Escherichia coli in developing countries, where the overuse of antibiotics is common. Information regarding β-lactamases, especially Extended-Spectrum β-Lactamases (ESBLs) in diarrheagenic pathogens should be considered in clinical management when an optimal treatment is needed. Objectives: The main objective of this study was to investigate the prevalence of blaCTX-M, blaSHV and blaTEM β-lactamase genes among enteropathogenic E. coli (EPEC) isolates in Tehran, Iran. Materials and Methods: Stool specimens were collected from children with diarrhea during a 17-month period from 2011 to 2013. Routine biochemical tests were performed for identification of E. coli isolates. The isolates were further examined by PCR for the presence of eae, stx1, stx2 and bfp genes. EPEC isolates have been screened for different β-lactamase genes. Genotyping EPEC isolates harboring blaCTX-M15 gene was performed through Multi-Locus VNTR Analysis (MLVA). Results: Of 42 EPEC, eight isolates carried the blaCTX-M1. None of the isolates carried blaCTX-M2 and blaCTX-M9. The blaCTX-M15 variant was identified in all of blaCTX-M1-positive isolates. Furthermore, blaSHV and blaTEM genes were detected in 40.5% (n = 17) and 19% (n = 8) of all EPEC isolates, respectively. No significant association was observed between the existence of bfp gene and presence of those β-lactamase genes (P > 0.05). MLVA analysis revealed high genetic diversity among blaCTX-M15-positive isolates. Conclusions: Our study emphasized the increasing role of ESBL genes, especially blaCTX-M15 in EPEC isolates. Keywords: Enteropathogenic Escherichia coli; Strains; Diarrhea